-
Halozyme Therapeutics, Inc. (NASDAQ:HALO) Q1 2025 Earnings Call Transcript
07 May 2025 12:41 GMT
… combined therapy of Perjeta, Herceptin and ENHANZE. Phesgo continues … mutated non-small cell lung cancer.
Subcutaneous Rybrevant represents a … presented at the European Lung Cancer Congress in March of … EGFR-mutated non-small cell lung cancer.
With a projected — …
-
Astellas Korea names ex-Novartis exec Kang as head of medical affairs
07 May 2025 02:05 GMT
… , covering key indications such as lung cancer, breast cancer, melanoma, and neuroendocrine … cancer in 14 years since Herceptin, and the first approved treatment …
-
Proposal To Fund Medicines For Lung Cancer, Breast Cancer And Respiratory Conditions
13 Sep 2024 00:42 GMT
… of advanced non-small-cell lung
cancer:
as a first treatment option …
since the emergence of trastuzumab (Herceptin) 20 years
ago."
Chair … .
Proposal
to fund treatments for lung cancer, breast cancer and
respiratory
conditions …
-
Targeted Treatments Shift the Paradigm of Advanced BTC
05 May 2025 15:30 GMT
… -targeted agents, [such as] trastuzumab [Herceptin], pertuzumab [Perjeta], or zanidatamab.”
In … in other cancers [such as] lung cancer when you treat these patients …
-
[Latest] Global Lung Tumor Market Size/Share Worth USD 46.3 Billion by 2033 at a 7.7% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
15 Apr 2024 16:30 GMT
… lung tumor diagnosis. This delay could result in the diagnosis of lung tumors … Related Reports: Lung Cancer Liquid Biopsy Market: Lung Cancer Liquid Biopsy … (Avastin), Rituximab (Rituxan), Trastuzumab (Herceptin), Cetuximab (Erbitux), Panitumumab (Vectibix), …
-
Advancing Pharmacists’ Role in Personalized Treatment for Breast, Prostate, and Lung Cancer
22 Feb 2024 14:19 GMT
… lung cancer, precision oncology has achieved notable advances. Lung cancer … ; Genentech), trastuzumab (Herceptin; Genentech), T-DM1 … Lung Cancer: From Broad Treatment to Individualized Approaches
Lung cancer … Immunotherapy in lung cancer. Transl Lung Cancer Res. …
-
REVEALED: From cancer to arthritis, how drug companies are selling treatments for 1,000 times what they cost to make - and the crippling cost to the NHS
29 Apr 2025 01:09 GMT
… , was suffering from stage 4 lung cancer, as shown by this scan … being diagnosed with stage 4 lung cancer in 2019.
This came after … ), Lemtrada (for multiple sclerosis) and Herceptin (for breast cancer).
The specific …
-
Fierce Pharma Asia—Enhertu's first-line win; Akeso bispecific's positive readout; Regeneron, Fujifilm's $3B deal
25 Apr 2025 14:54 GMT
… with chemotherapy in first-line lung cancer. Fujifilm Diosynth Biotechnologies signed a … the standard combination of Perjeta, Herceptin and chemotherapy. The two companies … -line squamous non-small cell lung cancer on progression-free survival. This …
-
Lung Cancer Surgery Market Worth USD 7.8 billion by 2030, Trends Analysis, Growth Rate, Share, Size, Revenue, Opportunities, Challenges, Key Drivers, Instrument, Procedure, Volume Data, Forecasts 2023-2030 | Exclusive Report by Delvens
15 May 2023 14:35 GMT
… of diagnosing and treating lung cancer Therapies for lung cancer can be broadly categorised … ;CAS9, Others), Drugs (Revlimid, Avastin, Herceptin, Rituxan, Opdivo, Gleevec, Imbruvica, Velcade …
-
Enhertu Combo Improves Progression in HER2+ Metastatic Breast Cancer
21 Apr 2025 20:31 GMT
… survival compared with taxane, Herceptin (trastuzumab) and Perjeta … plus Perjeta versus taxane, Herceptin and Perjeta.
Additionally, … Enhertu monotherapy versus taxane, Herceptin and Perjeta ,remains … mutant non-small cell lung cancer, HER2-positive gastric …
About
© 1995-2025